Breast Cancer Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 09
SKU : PH916
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
How big is the Breast Cancer Drugs Market ?
Global Breast Cancer Drugs Market reached USD 28.7 billion in 2022 and is projected to witness lucrative growth by reaching USD 57.1 billion by 2031.
Who are the key players in Breast Cancer Drugs Market ?
Major players are Novartis AG, F. Hoffmann-La Roche Ltd., AbbVie, Inc., Eli Lilly and Company, AstraZeneca, Merck & Co., Inc., Biocon Genzyme Corporation, MacroGenics, Inc., Janssen Global Services LLC, and Onyx Pharmaceuticals Inc.
Related Reports
medical-devices

Breast Cancer Screening and Diagnostic Techniques Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 February 01
Starting from

$4350

pharmaceuticals

Triple Negative Breast Cancer Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 February 22
Starting from

$4350

medical-devices

Breast Cancer Liquid Biopsy Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 January 30
Starting from

$4350

clinical-diagnostics

Breast Cancer Diagnostics Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 November 28
Starting from

$4350

pharmaceuticals

Breast Cyst Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2022 December 28
Starting from

$4350

pharmaceuticals

Blood Cancer Drugs Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 January 25
Starting from

$4350